Preserve Access to Affordable Generics and  Biosimilars Act limits anti-competitive pay for delay deals entered into by brandand  generic drug companies prevent affordable generic drugs or biosimilars from entering the market. Sen Klobuchar and  I led bill / voted out of cmte unanimously